Sperogenix Therapeutics, a platform company dedicated to developing and commercializing rare disease therapeutics in China, and Minoryx Therapeutics, a company that specializes in the development of i...
Read moreConnecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...
Read moreFunds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials
Read moreEl capital riesgo con participación internacional se incrementa un 67,1% y se erige como motor principal del crecimiento, según el Informe de la BioRegión 2020 - Retos en adelante, presentado por B...
Read moreAortyx, apoyada en su origen por IQS Tech Factory, ha sido la startup más votada en la final de los Premis Àlex Casta como mejor pitch de la Bioregión. La startup fundada y dirigida por Jordi Ma...
Read moreAseBio Investor Day’s round table on fundraising in Europe gathered EIT Health Investor Network’s main stakeholders
Read moreSparingVision (“the Company”), a genomic medicine company focused on ocular diseases, today announces a €44.5 million financing round. The round was led by 4BIO Capital (“4BIO”) and UPMC Ent...
Read moreThe Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes the last stage of the investment round with which this year it will ...
Read moreGalecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad r...
Read moreAzbil Corporation has been issued with an A+ rating from ‘Rating and Investment Information, Inc.’ The reason for the rating upgrade lies in that stable earnings sources, such as maintenance servi...
Read moreAtrys Health (BME:ATRY), compañía española que brinda servicios de diagnóstico y tratamiento médico de precisión y pionera en los ámbitos de la telemedicina y de la radioterapia de última gene...
Read moreYsios Capital, a leading Spanish biotechnology venture capital firm, today announced that its portfolio company Galecto Inc. has priced its initial public offering (IPO) and is trading on the Nasdaq G...
Read more